Toshiba introduces Adaptive Iterative Dose Reduction 3D technology at RSNA 2011

NewsGuard 100/100 Score

To make today's CT examinations even safer, Toshiba America Medical Systems, Inc., unveils next generation dose reduction technology, Adaptive Iterative Dose Reduction 3D (AIDR 3D, pending 510(k) clearance), at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 27 - Dec. 2, 2011 (Booth #5634, South Hall). AIDR 3D will be available on Toshiba's Aquilion ONE™, Aquilion™ Premium and Aquilion PRIME (pending 510(k) clearance) systems.

“With AIDR 3D, Toshiba has taken its dose reduction technology to the next level, allowing dose reduction to be easier and exams to be safer.”

AIDR 3D lowers radiation dose compared to conventional scanning, aiding clinicians in accurate diagnoses and treatment planning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise to maintain image quality.

"The AIDR 3D images look very similar to those reconstructed with classic filtered back projection. We have not noticed any plastic effect or loss of spatial resolution," said Professor Alain Blum, chief of radiology, Centre Hospitalier Universitaire, Nancy, France. "AIDR 3D is a fine solution to dramatically reduce X-ray dose and improve image quality, and should be immediately adopted when installed on your Toshiba CT system."

AIDR 3D has also been seamlessly integrated with SUREExposure™ 3D, a software that can calculate the minimum radiation exposure required for every exam. SUREExposure 3D adjusts dose for each patient based on a pre-set, targeted level of image quality.

"Integration of dose reduction technologies is essential for optimal dose management," said Joseph Cooper, director, CT Business Unit, Toshiba. "With AIDR 3D, Toshiba has taken its dose reduction technology to the next level, allowing dose reduction to be easier and exams to be safer."

Source Toshiba America Medical Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Azenta opens the doors to its new genomics laboratory in Oxford, UK